Tuesday, 19 Nov 2019

You are here

Lupus Outcomes Influenced by Race/Ethnicity

A lupus registry from San Francisco County analyzed racial/ethnic differences in lupus manifestations and found significant differences in SLE manifestations among racial/ethnic groups. Researchers found that Blacks, Asians/Pacific Islanders (API), and Hispanics are more likely to develop severe manifestations following a diagnosis of SLE.

From their database, they identified 724 SLE patients, and identified specific features in different subgroups. 

  • Renal manifestations: were increased in blacks, APIs, and Hispanics [PR 1.74, PR 1.68, PR 1.35,  respectively]
  • Neurologic manifestations: were increased in blacks [PR 1.49 (95%CI: 1.12–1.98)]
  • Hematologic disease: was increased in blacks [PR 1.09 (95%CI: 1.04–1.15)] and APIs [PR 1.07 (95%CI: 1.01–1.13)]
  • Lupus nephritis: blacks, APIs, and Hispanics had a higher risk of developing nephritis [HR 2.4, HR 4.3, HR 2.3]
  • Thrombocytopenia was more likely in  blacks, APIs, and Hispanics [HR 2.3, HR 2.3, HR 2.2, respectively].
  • Anti-Phospholipid syndrome: a higher risk was seen in APIs and Hispanics [HR 2.5, HR 2.6, respectively].


The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Part 1:  The “P” in Prednisone stands for Poison...and Other Pearls

Everyone has life hacks.  Years of experience and doing the same things repetitively allow us to figure out little tricks to make life easier. A rat in a maze, finding itself at a dead end, will back up and search for a clearing. If this rat encounters its neighbor, it will transmit that information so the second rat won’t make the same mistake.

Protective Effects of ASA and Vasodilators in Systemic Sclerosis

A large cohort study suggests that the use of vasodilators and aspirin (ASA) in systemic sclerosis (SSc) may yield favorable  cardiovascular outcomes.

Myositis Patients at High Risk of Opportunistic Infections

Among patients with systemic rheumatic diseases, the highest incidence of opportunistic infections was seen in those with polymyositis/dermatomyositis (PM/DM), Taiwanese researchers found.

Warfarin Superior to Xarelto in Antiphospholipid Syndrome

A 3 year, multicenter, European, study shows that rivaroxaban was inferior to warfarin in preventing thrombosis in patients with antiphospholipid syndrome (APS) according to the Annals of Internal Medicine. Thus despite the inconvenience of warfarin, it remains the best option for patients with APS.

Declining Trends in Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis Mortality in the USA

Annals of Internal Medicine reports that age-adjusted mortality rates for antineutrophil cytoplasmic autoantibody–associated vasculitides (AAV) have improved over time - with a decline of nearly 2 percent per year in the United States from 1999 to 2017. Nevertheless, long-term outcomes continue to lag behind mortality rates of the general population.